SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-21-015110
Filing Date
2021-04-30
Accepted
2021-04-30 12:47:44
Documents
4
Period of Report
2021-06-16

Document Format Files

Seq Description Document Type Size
1 DEF14A nc10023577x1_def14a.htm DEF 14A 996290
2 nc10023577x1_pc1.jpg GRAPHIC 579724
3 nc10023577x1_pc2.jpg GRAPHIC 406891
4 nc10023577x1_piechart.jpg GRAPHIC 164748
  Complete submission text file 0001140361-21-015110.txt   2582495
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35285 | Film No.: 21875639
SIC: 2836 Biological Products, (No Diagnostic Substances)